The U.S. Postal Service will run out of cash within a year unless Congress lifts a decades-old cap and allows the agency to ...

Q4 2025 earnings call recap: pemvidutide Phase III MASH plans, Phase II data, FDA status, cash runway to 2028—read now.

The Minnesota State High School League boys hockey state tournament continues today with the quarterfinal round for the state ...

The GMO Quality Strategy focuses its investments on companies with proven cash flows, differentiation, barriers to entry that ...

A consortium led by BlackRock and EQT is set to acquire AES in a US$33.bn deal, in which stokholders will receive US$15 per ...

WASHINGTON (AP) — President Donald Trump on Thursday fired his embattled Homeland Security Secretary Kristi Noem, after ...

Talks on landmark crypto legislation have hit a new impasse after banks said they could not back ⁠a compromise ⁠pushed by the ...

Cash and Investments -- $301.8 million as of December 31, 2025, sufficient to fully fund current Phase III HCV and new HEV programs through 2027. Phase III HCV Trials -- C BEYOND enrollment completed ...

For definitions of non-GAAP financial measures and reconciliations of GAAP to non-GAAP financial results, please refer to our ...

Flight Equipment Sales -- $20.9 million this quarter (four engines), compared to $31 million (six engines) in Q4 last year. Asset Management Segment Revenue -- Declined 11.1% to $56.9 million in Q4, ...

COPENHAGEN, Denmark, March 5, 2026 - Evaxion A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology platform, provides business up ...

Good afternoon, everyone, and welcome to the Atea Pharmaceuticals' Fourth Quarter 2025 Financial Results and Business Update Conference Call. [Operator Instructions] I would now like to turn the call ...